Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 12 (NPM1P12)

Target: NPM1P12
Molecular classification: Other, pseudogenes

Overview

Nucleophosmin 1 pseudogene 12 (NPM1P12) is a DNA sequence annotated as a pseudogene related to nucleophosmin 1, but it does not encode a functional protein and is not involved in biological or disease processes as a molecular target. Research and clinical applications in cancer primarily focus on the actual nucleophosmin 1 gene (NPM1) and its protein, particularly in the context of mutations in acute myeloid leukemia[4]. There is no direct information or evidence supporting any therapeutic, biological, or diagnostic relevance for NPM1P12.

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 12 (NPM1P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 12 (NPM1P12).

Explore the full profile